UC San Diego Health has been named a Center of Excellence for polycystic kidney disease (PKD) by the PKD Foundation – the leading advocacy group dedicated to finding treatments and a cure for PKD. UC San Diego Health is one of just 28 institutions nationwide to receive this designation.
Researchers aiming to predict which staph-infection patients might develop a related kidney disease have found a high frequency of gene mutations in the infecting bacteria of affected patients, which suggests these variants may play a role in the body’s initiation of the renal damage.
As medical schools across the country grapple with the arduous process of revising their curricula to be anti-racist, students at the Icahn School of Medicine at Mount Sinai have turned a critical eye on the very textbooks that have trained medical students for years.
Dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, reduced the risk for hospitalization for any cause in patients with chronic kidney disease (CKD) with and without type 2 diabetes.
Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces the publication of new real-world evidence (RWE) in Primary Care and Community Health demonstrating the Company’s KidneyIntelX bioprognostic™ test resulted in changed clinical decision making for patients in the early-stage of diabetic kidney disease (DKD) being cared for within the Mount Sinai Health System’s Population Health Ambulatory Pharmacy and Condition Management programs.
KidneyCure, the grants program supported by the American Society of Nephrology (ASN) Foundation, today announced that applications for its 2023 grants programs are now open. KidneyCure grants support clinical and basic research and kidney health investigators at key professional development milestones. The submission deadline is Wednesday, December 7, 2022, at 2:00 p.m. EST. Grant applications and guidelines can be found at https://www.kidneycure.org/
Unnecessarily high concentrations of oxygen given to patients under general anesthesia may increase risk of injury to the kidneys, lungs and heart, according to a large Vanderbilt University Medical Center-led study published in The BMJ, the flagship journal of the British Medical Association.
For patients with early-stage renal cell carcinomas (RCCs) that measure between 3 and 4 centimeters, a procedure that destroys the cancer by freezing – called cryoablation – yields a lower-risk of cancer-related death compared to heat-based thermal ablation, reports a preliminary study in The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
A recent analysis of clinical trial data estimates that treatment with the combination of angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers (ACE inhibitors/ARBs) and sodium-glucose cotransporter-2 (SGLT2) inhibitors can substantially increase the lifetime survival free of kidney failure for patients with albuminuric chronic kidney disease without diabetes.
This Thanksgiving, when the Moraleses think about what they’re thankful for, the Thompsons are at the top of the list.
The polycystic kidney disease (PKD) Foundation—the only organization in the U.S. dedicated solely to finding treatments and a cure for PKD recently named Mount Sinai Health System as a PKDF Partner Clinic for their desire to support patients with Autosomal Dominant PKD (ADPKD).
With a new grant that brings together engineering expertise from Missouri S&T and medical expertise from Saint Louis University’s School of Medicine, researchers are investigating how artificial intelligence can support matchmaking between donated kidneys and transplant centers to help more patients in need.
CHLA has received a new five-year award of $3.2 million from the National Institutes of Health (NIH) to research the underlying mechanisms that lead to kidney failure and to develop new treatments to protect kidney function.
The National Institutes of Health has awarded Albert Einstein College of Medicine a five-year, $6.6 million grant to lead a New York-based consortium of medical schools to train young scientists in kidney, urology, and hematology research.
Survey results from dialysis facilities in Australia and New Zealand indicate that environmental sustainability is not currently prioritized in facilities’ clinical practice, building design, or infrastructure and management systems.
Diabetes is a chronic health condition that impacts how the body turns food into energy. More than 37 million people in the United States have Type 2 diabetes, the most common form of the metabolic disorder, according to the Centers for Disease Control and Prevention. An additional 96 million adults have prediabetes and most of them are unaware they are developing a serious chronic disease.
Older adults with kidney failure in Europe experienced a considerable increase in symptom burden in the year before starting dialysis, which stabilized in the year after dialysis initiation.
Here are some of the latest articles that have been added to the Arthritis channel on Newswise.
In the battle of the sexes, women beat men in their ability to recover from kidney injury, but the reasons are not well understood. A study led by Duke Health researchers provides some insights: Females, it turns out, have an advantage at the molecular level that protects them from a form of cell death that occurs in injured kidneys. This protection could be exploited as a potential therapeutic.
Somatus, the nation's leading and largest value-based kidney care company, has received a 2022 Validation Program Report certifying the claim that kidney disease patients who receive Somatus Transition of Care Assessment (TCA) services have fewer hospital readmissions than similar patients who do not receive TCA services.
The American Society of Nephrology (ASN) is pleased to announce that Michelle A. Josephson, MD, FASN, will become the society’s next president. Dr. Josephson, who succeeds Susan E. Quaggin, MD, FASN, will assume her new role on January 1, 2023.
In clinical trials of patients with chronic kidney disease, combining information from the treatment effects on two markers of kidney disease progression—urinary albumin:creatinine ratio change and glomerular filtration rate slope—improves predictions of treatment effects on clinical endpoints.
Researchers have compared the impact of conservative management vs. dialysis on hospitalization outcomes in patients with advanced kidney disease across different races/ethnicities.
During 4 waves of the COVID-19 pandemic in New York City, the risk of severe COVID-19 was associated with pre-existing chronic kidney disease, as well as heart disease, diabetes, and hypertension.
During the COVID-19 pandemic in 2020, mortality risk for both COVID-19–positive and other patients on hemodialysis fluctuated in line with two waves of the pandemic in the general population.
Among US veterans with chronic kidney disease (CKD), Black individuals had a higher risk of developing kidney failure compared with White veterans, and their risk was more pronounced in the early years after kidney disease onset.
Among adults with normal kidney function, exposure to higher concentrations of components of air pollution was linked with higher risks of later developing chronic kidney disease.
A ToxSpotlight article in the November 2022 issue of ToxSci assesses the mechanism for cellular accumulation of diglycolic acid while another explores the effect of long-term St. John’s wort administration on acetaminophen-induced acute hepatotoxicity and the involved mechanisms.
The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person and online at ASN Kidney Week 2022 November 3–November 6.
• In a population-level study of 1,105 adults with stable glomerular disease (a type of autoimmune kidney disease), a first dose of a COVID-19 vaccine was not associated with relapse risk; however, receiving a subsequent vaccine dose was associated with a 2-fold higher relative risk of relapse. • Importantly, the increase in absolute risk associated with vaccination was low (1–5% depending on type of glomerular disease), and most vaccine-associated disease flares were mild.
Investigators recently developed and validated an artificial intelligence–based model that can help clinicians predict which patients in the intensive care unit are most likely to develop acute kidney injury.
Scientists have generated a polygenic risk score for pediatric steroid sensitive nephrotic syndrome, a kidney disease in children.
In an analysis of data from the Framingham Heart Study, albuminuria (a marker of kidney disease) was associated with signs of silent stroke, and patients with albuminuria had a higher risk of developing mild cognitive impairment or dementia.
Researchers have developed and validated an artificial intelligence–based algorithm to predict hospitalized patients’ risk of major adverse kidney events after discharge.
A new study led by Ochsner infectious diseases clinical pharmacist Kevin Lin, PharmD, was recently published in PLoS One, suggesting that oral cephalosporins are as safe and effective as the standard of care fluoroquinolones (FQs) for the treatment of acute kidney infections.
A recent analysis indicates that dapagliflozin is a cost-effective treatment in patients with chronic kidney disease in addition to standard of care.
The American College of Rheumatology (ACR) has released Continuing Medical Education (CME) for dermatologists and nephrologists to help them learn more about clinical trials for lupus patients in their treatment areas and the importance of getting more of African American/Black patients enrolled.
An analysis of the CHANCE-2 trial has found that persons with normal renal function receive greater benefit from antiplatelet therapy with ticagrelor–aspirin versus clopidogrel–aspirin. The analysis is published in Annals of Internal Medicine.
● The Congressional Kidney Caucus recognizes the 50th anniversary of the Medicare End-Stage Renal Disease (ESRD) Program. ● Kidney health leaders join the Congressional Kidney Caucus in calling for greater emphasis on intervening earlier and increasing disease awareness, increasing access to transplantation, and accelerating innovation in kidney health in the future of the ESRD Program.
New onset chronic kidney disease (CKD) in people with diabetes is highest among racial and ethnic minority groups compared with white persons, a UCLA-Providence study finds. The study, published as a letter to the editor in the New England Journal of Medicine, found that new onset CKD rates were higher by approximately 60%, 40%, 33%, and 25% in the Native Hawaiian/Pacific Islander, Black, American Indian/Alaska Native, and Hispanic/Latino populations, respectively, compared to white persons with diabetes.
● Among individuals with varying levels of chronic kidney disease who were not on dialysis, the prevalence of individual symptoms ranged from 24% (chest pain) to 83% (fatigue), and 98% of participants reported at least one symptom. ● Patients categorized as having a “Worse symptom score and worsening trajectory” of symptoms had higher risks of later needing dialysis and of dying before dialysis initiation.
The American Society of Nephrology (ASN) will hold Kidney Week, the world’s premier kidney meeting, in Orlando, FL, November 3–6, 2022. The results of scientific studies and high-impact clinical trials that will advance kidney-related research and medical care will be presented in-person and online.
In 2019, two Canadian provinces passed deemed consent legislation, where adults are automatically presumed to consent to organ donation upon their death unless they registered to opt out.
An international study led by a Rutgers scientist comparing new and older treatments against complicated urinary tract infections has found a new drug combination to be more effective, especially against stubborn, drug-resistant infections.
Researchers at Vanderbilt University Medical Center have found that the change in a single letter of the genetic code promotes, in a mouse model, the development of inflammation, high blood pressure and resulting kidney damage.
Researchers at the Miller School are looking for solutions to the continued effects of alcohol use, its harmful impact, and treatment. Understanding the mechanisms of alcohol abuse has gained importance, especially after the COVID-19 pandemic. Higher alcohol consumption led to an increased burden of pancreatic diseases in society.
Today, patients utilizing their Medicare Hospice Benefits with end-stage kidney disease (ESKD) are forced to make the traumatic choice between continuing dialysis or enrolling in hospice.
The use of next-generation, single-port surgical robots leads to improved cosmetic outcomes and patient perceptions of scarring after robotic kidney, bladder, or prostate surgery, reports a study in Urology Practice®, an Official Journal of the American Urological Association (AUA).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
